Micafungin and a case of polymorphic ventricular tachycardia

被引：2
|
作者：
Shah, P. J. [1 ]
Sundareshan, V. [2 ]
Miller, B. [3 ]
Bergman, S. J. [4 ]
机构：
[1] HSHS St Johns Hosp, Dept Pharm, Springfield, IL USA
[2] Southern Illinois Univ, Div Infect Dis, Sch Med, Springfield, IL USA
[3] Prairie Cardiovasc, Springfield, IL USA
[4] Southern Illinois Univ Edwardsville, Sch Pharm, Dept Pharm Practice, Edwardsville, IL USA
来源：
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2016年 / 41卷 / 03期
关键词：
amiodarone; antifungal; echinocandin; micafungin; polymorphic; torsades de pointes; ventricular tachycardia; TORSADES-DE-POINTES;
D O I：
10.1111/jcpt.12386
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
What is known and objective: Although echinocandins are relatively safe antifungal drugs, cardiovascular toxicity is an emerging adverse event. This report reviews those side effects and describes a case of polymorphic ventricular tachycardia suggestive of torsades de pointes with micafungin. Case description: The patient was on micafungin for oesophageal candidiasis due to drug-drug interactions with fluconazole and amiodarone. What is new and conclusion: This is the first known case of polymorphic ventricular tachycardia with micafungin as the possible cause. Clinicians should be aware of this potential adverse event and monitor patients receiving concomitant drugs that can prolong QT interval.
引用
收藏
页码：362 / 364
页数：3
相关论文
共 50 条
  • [1] Case of polymorphic ventricular tachycardia in diphenhydramine poisoning
    Joshi, AK
    Sljapic, T
    Borghei, H
    Kowey, PR
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (05) : 591 - 593
  • [2] A Case of Catecholaminergic Polymorphic Ventricular Tachycardia
    Lee, Seung-Yul
    Kim, Jin-Bae
    Im, Eui
    Yang, Woo-In
    Joung, Boyoung
    Lee, Moon-Hyoung
    Kim, Sung-Soon
    YONSEI MEDICAL JOURNAL, 2009, 50 (03) : 448 - 451
  • [3] AmiodaroneQT prolongation and polymorphic ventricular tachycardia: case report
    Reactions Weekly, 2001, 861 (1) : 7 - 7
  • [4] A Rare Trigger for Polymorphic Ventricular Tachycardia
    Zhang, Nan
    Wu, Ning
    Yan, Gan-Xin
    Zhang, Yubin
    Liu, Tong
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (01) : 185 - 187
  • [5] Catecholaminergic polymorphic ventricular tachycardia in a child: A case report
    Garabedian, Lara
    Verryckt, Ann
    Panzer, Joseph
    De Wolf, Daniel
    ACTA PAEDIATRICA, 2008, 97 (01) : 127 - 129
  • [6] Deadly Proposal A Case of Catecholaminergic Polymorphic Ventricular Tachycardia
    Heiner, Jason D.
    Bullard-Berent, Jeffrey H.
    Inbar, Shmuel
    PEDIATRIC EMERGENCY CARE, 2011, 27 (11) : 1065 - 1068
  • [7] Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: A comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes
    Brady, WJ
    DeBehnke, DJ
    Laundrie, D
    ACADEMIC EMERGENCY MEDICINE, 1999, 6 (06) : 609 - 617
  • [8] Polymorphic Ventricular Tachycardia: Torsade De Pointes or Purkinje Fiber Triggered Polymorphic Ventricular Tachycardia?.
    Coromilas, James
    Saluja, Amardeep
    Kostis, William J.
    Kassotis, John
    CIRCULATION, 2018, 138
  • [9] Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report
    Karaca, Mustafa
    Dinckal, Mustafa Hakan
    ACTA CARDIOLOGICA, 2006, 61 (04) : 481 - 484
  • [10] Polymorphic ventricular tachycardia and KCNJ2 mutations
    Chun, TUH
    Epstein, MR
    Dick, M
    Andelfinger, G
    Ballester, L
    Vanoye, CG
    George, AL
    Benson, DW
    HEART RHYTHM, 2004, 1 (02) : 235 - 241
12345